Literature DB >> 12116175

Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells.

Antonis K Moustakas1, George K Papadopoulos.   

Abstract

The major histocompatibility complex Class II alleles, HLA-DQ, and the related HLA-DR, are the chief genetic elements of human type 1 diabetes. These genes code for polymorphic heterodimeric proteins, whose chief function is to trap peptide antigens in the endosome and present them on the surface of antigen-presenting cells (dendritic cells, B lymphocytes, monocytes/macrophages) to CD4(+) T helper cells. A systematic investigation of the molecular properties of HLA-DQ alleles linked to susceptibility or resistance to type 1 diabetes has shown that these properties segregate along lines of susceptibility or resistance. A correlation of these features with the function of each particular segment of the HLA-DQ molecule yields interesting insights into the possible pathways leading to type 1 diabetes. There remain, however, areas to be clarified, including mechanisms by which dominant protection is conferred by certain alleles, the interplay between HLA-DQ and the related locus HLA-DR, that also shows autoantigen-specific reactivity, and the cross-Class help delivered to CD8(+) T cells, the final effectors in pancreatic beta-cell destruction. Clarification of these issues may lead to ways to prevent diabetes in predisposed individuals already exhibiting the genetic and immunological characteristics, and perhaps a cure in those with the disease, by means of transplantation, and measures for prevention of disease recurrence. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116175     DOI: 10.1002/ajmg.10342

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.

Authors:  Menno van Lummel; Peter A van Veelen; Arnaud Zaldumbide; Arnoud de Ru; George M C Janssen; Antonis K Moustakas; George K Papadopoulos; Jan W Drijfhout; Bart O Roep; Frits Koning
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

2.  The association between the HLA-G 14-bp insertion/deletion polymorphism and type 1 diabetes.

Authors:  H P V Silva; M A G Ururahy; K S C Souza; M B Loureiro; Y M C Oliveira; G H M Oliveira; A D Luchessi; K T C Carvalho; J C O C Freitas; E A Donadi; R D C Hirata; M G Almeida; R F Arrais; M H Hirata; A A Rezende
Journal:  Genes Immun       Date:  2015-10-22       Impact factor: 2.676

3.  DNA methylation and mRNA expression of HLA-DQA1 alleles in type 1 diabetes mellitus.

Authors:  Pavel Cepek; Marta Zajacova; Anna Kotrbova-Kozak; Elena Silhova; Marie Cerna
Journal:  Immunology       Date:  2016-03-07       Impact factor: 7.397

Review 4.  What can the HLA transgenic mouse tell us about autoimmune diabetes?

Authors:  F S Wong; L Wen
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

5.  The pancreatic β cell and type 1 diabetes: innocent bystander or active participant?

Authors:  Scott A Soleimanpour; Doris A Stoffers
Journal:  Trends Endocrinol Metab       Date:  2013-05-03       Impact factor: 12.015

6.  Multiple HLA epitopes contribute to type 1 diabetes susceptibility.

Authors:  Christina L Roark; Kirsten M Anderson; Lucas J Simon; Ronald P Schuyler; Michael T Aubrey; Brian M Freed
Journal:  Diabetes       Date:  2014-01       Impact factor: 9.461

7.  The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function.

Authors:  George P Bondinas; Antonis K Moustakas; George K Papadopoulos
Journal:  Immunogenetics       Date:  2007-05-12       Impact factor: 2.846

8.  Etiopathogenesis of insulin autoimmunity.

Authors:  Norio Kanatsuna; George K Papadopoulos; Antonis K Moustakas; Ake Lenmark
Journal:  Anat Res Int       Date:  2012-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.